Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Valion Bio (TIVC) Treasury Shares (2021 - 2025)

Valion Bio has reported Treasury Shares over the past 4 years, most recently at $79415.0 for Q2 2025.

  • For Q2 2025, Treasury Shares rose 1311.82% year-over-year to $79415.0; the TTM value through Jun 2025 reached $79415.0, up 1311.82%, while the annual FY2024 figure was $44119.0, N/A changed from the prior year.
  • Treasury Shares for Q2 2025 was $79415.0 at Valion Bio, roughly flat from $79415.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $93750.0 in Q1 2022 and troughed at -$938.0 in Q2 2022.
  • A 4-year average of $31458.3 and a median of $6562.5 in 2024 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: decreased 7.04% in 2022 and later soared 1311.82% in 2025.
  • Year by year, Treasury Shares stood at $1009.0 in 2021, then dropped by 7.04% to $938.0 in 2022, then surged by 4603.52% to $44119.0 in 2024, then surged by 80.0% to $79415.0 in 2025.
  • Business Quant data shows Treasury Shares for TIVC at $79415.0 in Q2 2025, $79415.0 in Q1 2025, and $44119.0 in Q4 2024.